Where is the live CopyMark page for USPTO serial 85645657?

The live record is at https://getcopymark.com/trademark/85645657. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns ZYMO PHARMACEUTICALS?

According to the public USPTO record for serial number 85645657, the listed owner(s) include: Zymo Research Corp..

What is USPTO serial number 85645657?

Serial number 85645657 is the USPTO application identifier for the mark ZYMO PHARMACEUTICALS. It is used to track examination, publication, and registration of this trademark.

What is the current status of ZYMO PHARMACEUTICALS?

ZYMO PHARMACEUTICALS (85645657) currently shows USPTO status code 603 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover ZYMO PHARMACEUTICALS?

The public record lists International Classes: 005. Each class corresponds to categories of goods or services identified in the application or registration.

4.9

433 reviews Get Help

4.9

USPTO serial 85645657

ZYMO PHARMACEUTICALS

Reviewed by CopyMark Law Group

Status 603

Filing date: Jun 7, 2012
Status date: Dec 1, 2014
Registration date: —
Examiner: FRUM MILONE, MARCIE R
Law office: TMO LAW OFFICE 116 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ZYMO PHARMACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Zymo Research Corp.
Irvine, CA
Other trademarks owned by Zymo Research Corp.

Goods and services

Class	Description	Status	First use
005	Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders	ACTIVE	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Dec 1, 2014	MAB3	ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL	—
Dec 1, 2014	ABN3	ABANDONMENT - AFTER EX PARTE APPEAL	—
Dec 1, 2014	EXPT	EXPARTE APPEAL TERMINATED	—
Oct 20, 2014	EXFB	EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF	—
Aug 1, 2014	GEA1	NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED	—
Aug 1, 2014	GECD	ACTION DENYING REQ FOR RECON E-MAILED	—
Aug 1, 2014	CNCF	ACTION CONTINUING FINAL - COMPLETED	—
Jul 15, 2014	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Jul 15, 2014	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Jul 8, 2014	ERFR	TEAS REQUEST FOR RECONSIDERATION RECEIVED	—
Jul 8, 2014	EXPI	EX PARTE APPEAL-INSTITUTED	—
Jul 8, 2014	JURT	JURISDICTION RESTORED TO EXAMINING ATTORNEY	—
Jul 8, 2014	EXAF	EXPARTE APPEAL RECEIVED AT TTAB	—
Jan 9, 2014	GNFN	NOTIFICATION OF FINAL REFUSAL EMAILED	—
Jan 9, 2014	GNFR	FINAL REFUSAL E-MAILED	A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 9, 2014	CNFR	FINAL REFUSAL WRITTEN	A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 3, 2013	RCCK	SUSPENSION CHECKED - TO ATTORNEY FOR ACTION	—
Apr 3, 2013	DMCC	DATA MODIFICATION COMPLETED	—
Apr 3, 2013	ALIE	ASSIGNED TO LIE	—
Apr 2, 2013	GNS3	NOTIFICATION OF LETTER OF SUSPENSION E-MAILED	—
Apr 2, 2013	GNSL	LETTER OF SUSPENSION E-MAILED	—
Apr 2, 2013	CNSL	SUSPENSION LETTER WRITTEN	—
Apr 1, 2013	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
Mar 31, 2013	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Mar 31, 2013	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 30, 2012	GNRN	NOTIFICATION OF NON-FINAL ACTION E-MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 30, 2012	GNRT	NON-FINAL ACTION E-MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 30, 2012	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 22, 2012	DOCK	ASSIGNED TO EXAMINER	—
Jun 18, 2012	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	—
Jun 11, 2012	NWAP	NEW APPLICATION ENTERED	—